Hostname: page-component-cd9895bd7-lnqnp Total loading time: 0 Render date: 2024-12-18T14:10:25.707Z Has data issue: false hasContentIssue false
  • English
  • Français

Danon disease: characteristic late gadolinium enhancement pattern on cardiac magnetic resonance imaging

Published online by Cambridge University Press:  19 May 2011

Bharat S. Dara ,
Paolo G. Rusconi  and
Joel E. Fishman
Bharat S. Dara
Affiliation:
Departments of Pediatrics, Miller School of Medicine, University of Miami, Miami, Florida, United States of America
Paolo G. Rusconi
Affiliation:
Departments of Pediatrics, Miller School of Medicine, University of Miami, Miami, Florida, United States of America
Joel E. Fishman*
Affiliation:
Departments of Radiology, Miller School of Medicine, University of Miami, Miami, Florida, United States of America
*
Correspondence to: Dr J. E. Fishman, MD, PhD, Department of Radiology, Miller School of Medicine, University of Miami, 1115 NW 14th Street, Miami, Florida 33136, United States of America. Tel: (305)243 9193 office; Fax: (305)243 2439; E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Danon disease is a rare entity associated with the clinical triad of mental retardation, skeletal myopathy, and severe hypertrophic cardiomyopathy. We report two cases of Danon disease and describe the results of the cardiac magnetic resonance imaging studies that were conducted to assess the pattern of cardiac hypertrophy.

Keywords

Cardiomyopathycardiac magnetic resonance imagingDanon diseaseLAMP2
Type
Brief Reports
Information
Cardiology in the Young , Volume 21 , Issue 6 , 28 October 2011 , pp. 707 - 709
Copyright
Copyright © Cambridge University Press 2011

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Maron, MJ, Roberts, WC, Arad, M, et al. Clinical outcome and phenotypic expression in LAMP2 cardiomyopathy. JAMA 2009; 301: 1253–1259.Google Scholar
2.Piotrowska-Kownacka, D, Kownacki, L, Kuch, M, et al. Cardiovascular magnetic resonance findings in a case of danon disease. J Cardiovasc Magn Reson 2009; 11: 12–16.Google Scholar
3.Adabag, AS, Maron, BJ, Appelbaum, E, et al. Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance. J Am Coll Cardiol 2008; 51: 1369–1374.Google Scholar
4.Choudhury, L, Mahrholdt, H, Wagner, A, et al. Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 2002; 40: 2156–2164.CrossRefGoogle ScholarPubMed